Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 2 | 82.4% |
| Food and Beverage | $42.85 | 2 | 17.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $200.00 | 2 | $0 (2021) |
| GlaxoSmithKline, LLC. | $42.85 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.40 | 1 | GlaxoSmithKline, LLC. ($13.40) |
| 2021 | $200.00 | 2 | BOSTON SCIENTIFIC CORPORATION ($200.00) |
| 2020 | $29.45 | 1 | GlaxoSmithKline, LLC. ($29.45) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/04/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: IMMUNOLOGY | ||||||
| 06/22/2021 | Boston Scientific Corporation | GENERAL PULMONARY (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $139.50 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/22/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL PULMONARY (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $60.50 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/30/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,222 | 1,388 | $361,711 | $84,694 |
| 2022 | 18 | 1,127 | 1,336 | $340,778 | $87,670 |
| 2021 | 19 | 1,064 | 1,243 | $337,524 | $91,156 |
| 2020 | 19 | 993 | 1,143 | $289,975 | $76,709 |
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 238 | 289 | $100,480 | $22,921 | 22.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 40 | 88 | $64,416 | $15,641 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 81 | 108 | $51,316 | $12,840 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 70 | 70 | $34,735 | $7,415 | 21.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 53 | $16,861 | $5,340 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 85 | 86 | $21,186 | $4,458 | 21.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 47 | $10,314 | $3,149 | 30.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 27 | $10,824 | $2,972 | 27.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 17 | $10,081 | $2,496 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $8,893 | $2,148 | 24.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 185 | 186 | $8,016 | $1,354 | 16.9% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 60 | 60 | $6,268 | $1,085 | 17.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 121 | 122 | $7,547 | $1,028 | 13.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 102 | 103 | $5,908 | $990.00 | 16.8% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 106 | 106 | $4,062 | $713.44 | 17.6% |
| 94375 | Test to measure rate of airflow | Facility | 2023 | 12 | 12 | $804.00 | $144.24 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 203 | 276 | $87,790 | $22,419 | 25.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 42 | 107 | $71,772 | $19,787 | 27.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 79 | 107 | $47,258 | $13,035 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 74 | 74 | $35,422 | $8,297 | 23.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 56 | $16,850 | $4,900 | 29.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 35 | 39 | $8,196 | $3,256 | 39.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 18 | 18 | $10,728 | $2,704 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 52 | 52 | $11,524 | $2,696 | 23.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $6,954 | $2,035 | 29.3% |
About Dr. Daniel Fitelson, MD
Dr. Daniel Fitelson, MD is a Critical Care Medicine healthcare provider based in Burlington, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2009. The National Provider Identifier (NPI) number assigned to this provider is 1053545459.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Fitelson, MD has received a total of $242.85 in payments from pharmaceutical and medical device companies, with $13.40 received in 2023. These payments were reported across 4 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($200.00).
As a Medicare-enrolled provider, Fitelson has provided services to 4,406 Medicare beneficiaries, totaling 5,110 services with total Medicare billing of $340,229. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Burlington, MA
- Active Since 05/13/2009
- Last Updated 11/21/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1053545459
Products in Payments
- GENERAL PULMONARY (Device) $200.00
- TRELEGY ELLIPTA (Drug) $29.45
- NUCALA (Biological) $13.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Burlington
Ioana Preston, Md, MD
Critical Care Medicine — Payments: $495,322
Adam Smith, Md, MD
Critical Care Medicine — Payments: $350,856
Dr. David Kaminsky, Md, MD
Critical Care Medicine — Payments: $29,888
Dr. Cyrus Kholdani, Md, MD
Critical Care Medicine — Payments: $16,195
Timothy Liesching, M.d, M.D
Critical Care Medicine — Payments: $15,303
Dr. Dirk Varelmann, M.d, M.D
Critical Care Medicine — Payments: $5,723